Protection of the ischemic myocardium from reperfusion injury by prostaglandin E1 inhibition of ischemia-induced neutrophil activation

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 338, Issue 3, 1988, Pages 268-274

  Schrör, Karsten ^a   Thiemermann, Christoph ^a,b   Ney, Peter ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Myeloperoxidase; Myocardial reperfusion injury; Platelets; Polymorphonuclear leukocytes; Prostaglandin E1 (PGE1)

Indexed keywords

PROSTAGLANDIN E1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD PRESSURE; CAT; CYTOLOGY; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

ALPROSTADIL; ANIMAL; BLOOD PRESSURE; CATS; CORONARY DISEASE; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; LEUKOCYTE COUNT; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NEUTROPHILS; PEROXIDASE; PLATELET COUNT; SUPPORT, NON-U.S. GOV'T;

EID: 0023785283     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/BF00173399     Document Type: Article

References (39)

1. Prevention of blockage of partially obstructed coronary arteries with prostacyclin correlates with inhibition of platelet aggregation
2. Role of prostacyclin in the preservation of ischemic myocardial tissue in the perfused cat heart
3. A critical look at currently used indirect indices of myocardial oxygen consumption
4. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
5. Effects of iloprost, a stable prostacyclin analog, on exercise capacity and platelet aggregation in stable angina pectoris
6. Accumulation of unesterified arachidonic acid in ischemic canine myocardium
7. 2 agonist
8. Mechanism of the luminoldependent chemiluminescence of human neutrophils
9. 2 modification of superoxide production by human neutrophils
10. Chemotactic and chemokinetic stimulation of human eosinophil and neutrophil polymorphonuclear leukocyte chemotaxis and random migration by 12- l-hydroxy-5,8,10,14-eicosatetraenoic acid
11. 1 in man
12. 2α on the sympathetically stimulated rabbit heart
13. Canine myocardial reperfusion injury: its reduction by the combined administration of superoxide dismutase and catalase
14. 2 on myocardial infarct size after coronary artery occlusion in conscious dogs
15. Measurement of chemiluminescence in freshly drawn human blood. I. Role of granulocytes, platelets and platelet factors in zymosan-induced chemiluminescence
16. Leukocytes and ischemia-induced myocardial injury
17. Temporal changes in 12-HETE formation in two models of canine myocardial infarction
18. Platelet depletion and infarct size in an occlusion-reperfusion model of myocardial ischemia in anaesthetized dogs
19. Role of leukocytes in acute myocardial infarction in anaesthetized dogs: Relationship to myocardial salvage by antiinflammatory drugs
20. Studies on the protective effect of prostacyclin in acute myocardial ischemia
21. Accumulation of nonesterified fatty acids in ischemic canine myocardium
22. The stimulation of arachidonic acid metabolism in human platelets by hydrodynamic stress
23. Reduction of the extent of ischemic injury by neutrophil depletion in the dog
24. Improved procedure for creatine phosphokinase determination
25. Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle
26. Prostaglandins and myocardial noradrenaline overflow after sympathetic nerve stimulation during ischemia and reperfusion
27. 2-like activity
28. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia
29. 1 plus streptokinase in acute myocardial infarction
30. Myocardial calcium and magnesium in acute ischemic injury
31. Iloprost inhibits neutrophil function in vitro and in vivo and limits experimental infarct size in canine heart
32. Prostacyclin protects ischemic reperfused myocardium in the dog by inhibition of neutrophil activation
33. I — Inhibition of neutrophil migration and activation
34. Effect of iloprost (ZK 36 374) on membrane integrity in ischemic rabbit hearts
35. Experimental acute myocardial infarction induced by temporary or permanent occlusion of a coronary artery
36. Prostaglandins in therapy of cardiovascular disease
37. 1 in acute myocardial infarction
38. Usefulness of defibrotide in protecting ischemic myocardium from reperfusion damage
39. Comparison of the thromboxane synthetase inhibitor dazoxiben and the prostacyclin mimetic iloprost (ZK 36 374) in an animal model of acute myocardial ischemia and reperfusion